|
(BS254) |
Effects of atrial fibrillation on the human ventricle |
| |
|
S. Pabel, M. Knierim, S. Ahmad, J. Herting, D. Hollemann, C. Brochhausen, T. H. Fischer, G. Hasenfuß, L. S. Maier, K. Streckfuß-Bömeke, S. T. Sossalla (Regensburg, Göttingen, Coburg) |
|
(BS255) |
Variants in calcium regulatory cardiac genes and their role in predisposition for Takotsubo syndrome |
| |
|
F. Treu, N. Dybkova, P. Jung, Y. Li, D. Hübscher, W. Maurer, G. Hasenfuß, N. Voigt, S. T. Sossalla, B. Wollnik, K. Streckfuß-Bömeke (Göttingen, Regensburg) |
|
(BS256) |
SGLT-1/2 inhibition with Sotagliflozin improved cardiac function in a metabolic-based HFpEF model |
| |
|
U. Primessnig, N. Hegemann, L. Clemens, N. Beindorff, P. Wakula, J. Grune, W. Kübler, F. Hohendanner, B. Pieske, D. Messroghli, F. R. Heinzel (Berlin) |
|
(BS257) |
Intrinsic cardiac ganglia and the memory of cardioprotection from remote ischemic conditioning |
| |
|
H. R. Lieder, A. Irmert, V. Adam, G. Heusch, P. Kleinbongard (Essen) |
|
(BS258) |
Effects of dual SGLT-1 and SGLT-2 inhibition on contraction and myofilament sensitivity in a model of metabolic HFpEF |
| |
|
J. B. Ritter, F. Hohendanner, P. Wakula, L. Clemens, D. Bode, N. Hegemann, U. Primessnig, B. Pieske, D. Messroghli, F. R. Heinzel (Berlin) |
|
(BS259) |
Immune checkpoint inhibitor driven myocarditis – a case series exemplifies the variable phenotype |
| |
|
D. Finke, J. Riffel, J. Salatzki, B. Jordan, H. A. Katus, L. H. Lehmann (Heidelberg) |
|
(BS260) |
Chronic transcutaneous water loss drives catabolism and arterial hypertension in experimental psoriasis |
| |
|
J. Wild, R. Schüler, T. Knopp, M. Molitor, P. Efentakis, D. Benaki, E. Mikros, T. Münzel, K. Kitada, A. Waisman, J. Titze, P. Wenzel, S. Karbach (Mainz, Athens; Singapore, SG) |